Bigger in Japan: Biopta CEO predicts preclinical CRO business growth under new owners
Preclinical CRO Biopta will add stem cell programming tech to its offering, expand in Japan and nearly double its workforce under new owner, Reprocell.
Archives for November 26, 2015
Acquired Sigma-Aldrich businesses part of Merck's Africa growth plan
New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck*.